Naphthalimides as Anticancer Agents: Synthesis and Biological Activity
Current Medicinal Chemistry-Anti-Cancer Agents · 2001
DOI: 10.2174/1568011013354624 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von M F Braña und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Orgánica y Farmacéutica, Facultad de Ciencias Experimentales, Universidad San Pablo-CEU, Montepríncipe. Boadilla del Monte, 2…. Die Arbeit wurde bisher 200-mal zitiert (Crossref).
Abstract (Originalsprache)
Naphthalimides are a class of compounds with high antitumor activity upon a variety of murine and human tumor cells. These compounds bind to DNA by intercalation of the chromophore and two of them, mitonafide and amonafide, were used in clinical trials. The therapeutic properties of these lead drugs were improved by designing bisintercalating agents. One of these, elinafide, showed intense in vitro and in vivo activity and is currently being used in clinical trials against solid tumors. In this paper, the history of elinafide is described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Química Orgánica y Farmacéutica, Facultad de Ciencias Experimentales, Universidad San Pablo-CEU, Montepríncipe. Boadilla del Monte, 28668-Madrid, Spain.
Zitieren
APA
Braña, M. F., & Ramos, A. (2001). Naphthalimides as Anticancer Agents: Synthesis and Biological Activity. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354624
Vancouver
Braña MF, Ramos A. Naphthalimides as Anticancer Agents: Synthesis and Biological Activity. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354624
BibTeX
@article{Braa2001,
author = {Braña, M F and Ramos, A},
title = {Naphthalimides as Anticancer Agents: Synthesis and Biological Activity},
journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
year = {2001},
doi = {10.2174/1568011013354624}
}
EUVIMED